The role of histone methylation in the development of digestive cancers: a potential direction for cancer management

Y Chen, B Ren, J Yang, H Wang, G Yang… - Signal transduction and …, 2020 - nature.com
Digestive cancers are the leading cause of cancer-related death worldwide and have high
risks of morbidity and mortality. Histone methylation, which is mediated mainly by lysine …

Pancreatic cancer heterogeneity can be explained beyond the genome

NA Juiz, J Iovanna, N Dusetti - Frontiers in oncology, 2019 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) remains a major health problem because it
induces almost systematic mortality. Carcinogenesis begins with genetic aberrations which …

Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer

M Guo, S Lu, H Huang, Y Wang, MQ Yang, Y Yang… - BMC systems …, 2018 - Springer
Background Bladder cancer (BC) is the most common cancer of the urinary bladder and
upper tract, in which the clinical management is limited. AURKA (aurora kinase A) has been …

Double the chemistry, double the fun: Structural diversity and biological activity of marine-derived diketopiperazine dimers

NGM Gomes, RB Pereira, PB Andrade, P Valentão - Marine drugs, 2019 - mdpi.com
While several marine natural products bearing the 2, 5-diketopiperazine ring have been
reported to date, the unique chemistry of dimeric frameworks appears to remain neglected …

Targeting epigenetic aberrations in pancreatic cancer, a new path to improve patient outcomes?

BD Paradise, W Barham, ME Fernandez-Zapico - Cancers, 2018 - mdpi.com
Pancreatic cancer has one of the highest mortality rates among all types of cancers. The
disease is highly aggressive and typically diagnosed in late stage making it difficult to treat …

Pharmacoepigenetic processors: epigenetic drugs, drug resistance, toxicoepigenetics, and nutriepigenetics

R Cacabelos, JC Carril, A Sanmartín, P Cacabelos - Pharmacoepigenetics, 2019 - Elsevier
The pharmacoepigenetic apparatus is integrated by gene clusters of different categories,
including (i) pathogenic genes involved in disease pathogenesis,(ii) mechanistic genes …

[HTML][HTML] Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells

NA Fraunhoffer, AIM Vega, AM Abuelafia, M Morvan… - …, 2023 - thelancet.com
Background Systems biology leveraging multi-OMICs technologies, is rapidly advancing
development of precision therapies and matching patients to targeted therapies, leading to …

Therapeutic potential of mitotic kinases' inhibitors in cancers of the gastrointestinal system

A Javed, G Malagraba, M Yarmohammadi… - Future …, 2022 - mdpi.com
Mitosis entails mechanistic changes required for maintaining the genomic integrity in all
dividing cells. The process is intricate and temporally and spatially regulated by the ordered …

Combined targeting of G9a and checkpoint kinase 1 synergistically inhibits pancreatic cancer cell growth by replication fork collapse

G Urrutia, A Salmonson, J Toro-Zapata… - Molecular Cancer …, 2020 - AACR
Because of its dismal outcome, pancreatic ductal adenocarcinoma (PDAC) remains a
therapeutic challenge making the testing of new pharmacologic tools a goal of paramount …

Gene coexpression network analysis reveals perirenal adipose tissue as an important target of prenatal malnutrition in sheep

S Ahmad, MH Drag, S Mohamad Salleh… - Physiological …, 2023 - journals.physiology.org
We have previously demonstrated that pre-and early postnatal malnutrition in sheep
induced depot-and sex-specific changes in adipose morphological features, metabolic …